MARKET

XENE

XENE

Xenon Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.77
+0.02
+0.23%
Closed 16:00 11/15 EST
OPEN
8.70
PREV CLOSE
8.75
HIGH
9.04
LOW
8.66
VOLUME
101.27K
TURNOVER
--
52 WEEK HIGH
11.34
52 WEEK LOW
5.41
MARKET CAP
226.87M
P/E (TTM)
-6.0412
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of XENE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

XENE News

  • Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
  • GlobeNewswire.8h ago
  • Is Xenon Pharmaceuticals Inc (XENE) A Good Stock To Buy?
  • Insider Monkey.4d ago
  • Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/06 03:40
  • Xenon Pharma EPS beats by $0.13
  • seekingalpha.11/06 02:04

More

Industry

Biotechnology & Medical Research
+1.49%
Pharmaceuticals & Medical Research
+1.29%

Hot Stocks

Name
Price
%Change

About XENE

Xenon Pharmaceuticals Inc is a Canada-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its product pipeline includes: Glybera, TV-45070, GDC-0310, XEN901 (Nav1.6 inhibitor) and XEN1101. Glybera is used for the treatment of lipoprotein lipase deficiency (LPLD). Specifically, it is intended to treat LPLD in patients with severe or multiple pancreatitis attacks, despite dietary fat restrictions. TV-45070 is a small-molecule inhibitor of the sodium channel Nav1.7 and other sodium channels, including those that are expressed in the pain-sensing peripheral nervous system. XEN901 is developed for the treatment of rare infantile epileptic encephalopathy and other forms of epilepsy. XEN1101, is a potassium channel modulator for the treatment of epilepsy. Its Extreme Genetics discovery platform enables the Company to identify drug targets that are more biologically relevant in humans.
More

Webull offers Xenon Pharmaceuticals Inc (XENE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.